Crossmark

Treatment of malignant pleural effusions: the case for localized immunotherapy

Crossref DOI link: https://doi.org/10.1186/s40425-019-0590-4

Published Online: 2019-04-18

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Donnenberg, Albert D. https://orcid.org/0000-0002-6723-3330
Luketich, James D.

Dhupar, Rajeev

Donnenberg, Vera S.
Funding

Funding for this research was provided by:

National Cancer Institute (R21 CA191647)

Department of Defense (W81XWH-14-0258)
License Information

Text and Data Mining valid from 2019-04-18
More Information

Article History

Received: 3 December 2018

Accepted: 2 April 2019

First Online: 18 April 2019

Ethics approval and consent to participate

: Not applicable.

: All authors consent.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.